Genetic disruption of USP9X sensitizes colorectal cancer cells to 5-fluorouracil

Dennis R. Harris, Alexandra Mims, Fred Bunz

Research output: Contribution to journalArticle

Abstract

The X-linked deubiquitinase USP 9X affects the stability and activity of numerous regulatory proteins that influence cell survival. Recent studies suggest that decreased USP 9X expression can confer a selective advantage onto developing cancer cells and thereby promotes disease progression. To examine the effect of USP 9X on the cellular responses to anticancer therapies, we derived cancer cell lines in which the USP9X locus was disrupted by homologous recombination. The resulting USP 9X-deficient cancer cells exhibited increased activation of apoptotic pathways and markedly decreased clonogenic survival in response to 5-fluorouracil, a chemotherapeutic drug that is widely used for treatment of gastrointestinal malignancies. These unexpected results suggest that cancers with low USP9X expression might be specifically sensitized to some conventional therapeutic agents.

Original languageEnglish (US)
Pages (from-to)1319-1324
Number of pages6
JournalCancer Biology and Therapy
Volume13
Issue number13
DOIs
StatePublished - Nov 2012

Fingerprint

Fluorouracil
Colorectal Neoplasms
Neoplasms
Homologous Recombination
Disease Progression
Cell Survival
Cell Line
Therapeutics
Pharmaceutical Preparations
Proteins

Keywords

  • 5-fluorouracil
  • Apoptosis
  • Chemotherapy
  • Gene targeting
  • P53
  • Resistance
  • USP9X

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Molecular Medicine
  • Pharmacology

Cite this

Genetic disruption of USP9X sensitizes colorectal cancer cells to 5-fluorouracil. / Harris, Dennis R.; Mims, Alexandra; Bunz, Fred.

In: Cancer Biology and Therapy, Vol. 13, No. 13, 11.2012, p. 1319-1324.

Research output: Contribution to journalArticle

Harris, Dennis R. ; Mims, Alexandra ; Bunz, Fred. / Genetic disruption of USP9X sensitizes colorectal cancer cells to 5-fluorouracil. In: Cancer Biology and Therapy. 2012 ; Vol. 13, No. 13. pp. 1319-1324.
@article{02cc095f52864ef5bbae71d46ca2d9ae,
title = "Genetic disruption of USP9X sensitizes colorectal cancer cells to 5-fluorouracil",
abstract = "The X-linked deubiquitinase USP 9X affects the stability and activity of numerous regulatory proteins that influence cell survival. Recent studies suggest that decreased USP 9X expression can confer a selective advantage onto developing cancer cells and thereby promotes disease progression. To examine the effect of USP 9X on the cellular responses to anticancer therapies, we derived cancer cell lines in which the USP9X locus was disrupted by homologous recombination. The resulting USP 9X-deficient cancer cells exhibited increased activation of apoptotic pathways and markedly decreased clonogenic survival in response to 5-fluorouracil, a chemotherapeutic drug that is widely used for treatment of gastrointestinal malignancies. These unexpected results suggest that cancers with low USP9X expression might be specifically sensitized to some conventional therapeutic agents.",
keywords = "5-fluorouracil, Apoptosis, Chemotherapy, Gene targeting, P53, Resistance, USP9X",
author = "Harris, {Dennis R.} and Alexandra Mims and Fred Bunz",
year = "2012",
month = "11",
doi = "10.4161/cbt.21792",
language = "English (US)",
volume = "13",
pages = "1319--1324",
journal = "Cancer Biology and Therapy",
issn = "1538-4047",
publisher = "Landes Bioscience",
number = "13",

}

TY - JOUR

T1 - Genetic disruption of USP9X sensitizes colorectal cancer cells to 5-fluorouracil

AU - Harris, Dennis R.

AU - Mims, Alexandra

AU - Bunz, Fred

PY - 2012/11

Y1 - 2012/11

N2 - The X-linked deubiquitinase USP 9X affects the stability and activity of numerous regulatory proteins that influence cell survival. Recent studies suggest that decreased USP 9X expression can confer a selective advantage onto developing cancer cells and thereby promotes disease progression. To examine the effect of USP 9X on the cellular responses to anticancer therapies, we derived cancer cell lines in which the USP9X locus was disrupted by homologous recombination. The resulting USP 9X-deficient cancer cells exhibited increased activation of apoptotic pathways and markedly decreased clonogenic survival in response to 5-fluorouracil, a chemotherapeutic drug that is widely used for treatment of gastrointestinal malignancies. These unexpected results suggest that cancers with low USP9X expression might be specifically sensitized to some conventional therapeutic agents.

AB - The X-linked deubiquitinase USP 9X affects the stability and activity of numerous regulatory proteins that influence cell survival. Recent studies suggest that decreased USP 9X expression can confer a selective advantage onto developing cancer cells and thereby promotes disease progression. To examine the effect of USP 9X on the cellular responses to anticancer therapies, we derived cancer cell lines in which the USP9X locus was disrupted by homologous recombination. The resulting USP 9X-deficient cancer cells exhibited increased activation of apoptotic pathways and markedly decreased clonogenic survival in response to 5-fluorouracil, a chemotherapeutic drug that is widely used for treatment of gastrointestinal malignancies. These unexpected results suggest that cancers with low USP9X expression might be specifically sensitized to some conventional therapeutic agents.

KW - 5-fluorouracil

KW - Apoptosis

KW - Chemotherapy

KW - Gene targeting

KW - P53

KW - Resistance

KW - USP9X

UR - http://www.scopus.com/inward/record.url?scp=84868374682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868374682&partnerID=8YFLogxK

U2 - 10.4161/cbt.21792

DO - 10.4161/cbt.21792

M3 - Article

VL - 13

SP - 1319

EP - 1324

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

SN - 1538-4047

IS - 13

ER -